In this podcast, Daniel R. Kuritzkes, MD, talks about HIV resistance in the context of pre-exposure prophylaxis (PrEP) use, how common it is, and how PrEP might influence subsequent therapies. More at: www.consultant360.com/infectious-diseases.

In this podcast, Daniel R. Kuritzkes, MD, talks about HIV resistance in the context of pre-exposure prophylaxis (PrEP) use, how common it is, and how PrEP might influence subsequent therapies. More at: www.consultant360.com/infectious-diseases.

In this podcast,&nbsp;Daniel R. Kuritzkes, MD, talks about HIV resistance in the context of pre-exposure prophylaxis (PrEP) use, how common it is, and how PrEP might influence subsequent therapies. More at: www.consultant360.com/infectious-diseases.

Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP

Sign up to save your podcasts

Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP

Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast